DE69230541T2 - Liposompräparat enthaltend eine tricyclische Verbindung - Google Patents

Liposompräparat enthaltend eine tricyclische Verbindung

Info

Publication number
DE69230541T2
DE69230541T2 DE69230541T DE69230541T DE69230541T2 DE 69230541 T2 DE69230541 T2 DE 69230541T2 DE 69230541 T DE69230541 T DE 69230541T DE 69230541 T DE69230541 T DE 69230541T DE 69230541 T2 DE69230541 T2 DE 69230541T2
Authority
DE
Germany
Prior art keywords
tricyclic compound
preparation containing
liposome
liposome preparation
incorporated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69230541T
Other languages
English (en)
Other versions
DE69230541D1 (de
Inventor
Akira Kagayama
Yuji Tokunaga
Atsunori Kaibara
Sachiyo Tanimoto
Takehisa Hata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69230541D1 publication Critical patent/DE69230541D1/de
Publication of DE69230541T2 publication Critical patent/DE69230541T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
DE69230541T 1991-10-31 1992-10-26 Liposompräparat enthaltend eine tricyclische Verbindung Expired - Lifetime DE69230541T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31342291 1991-10-31
PCT/JP1992/001388 WO1993008802A1 (en) 1991-10-31 1992-10-26 Liposome preparation containing tricyclic compound

Publications (2)

Publication Number Publication Date
DE69230541D1 DE69230541D1 (de) 2000-02-10
DE69230541T2 true DE69230541T2 (de) 2000-08-24

Family

ID=18041109

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230541T Expired - Lifetime DE69230541T2 (de) 1991-10-31 1992-10-26 Liposompräparat enthaltend eine tricyclische Verbindung

Country Status (9)

Country Link
EP (1) EP0658344B1 (de)
KR (1) KR100253492B1 (de)
AT (1) ATE188378T1 (de)
CA (1) CA2122344C (de)
DE (1) DE69230541T2 (de)
DK (1) DK0658344T3 (de)
ES (1) ES2140419T3 (de)
GR (1) GR3032319T3 (de)
WO (1) WO1993008802A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
AU775694B2 (en) * 1999-03-11 2004-08-12 Fujisawa Pharmaceutical Co., Ltd. Liposome preparations
AU7452900A (en) * 1999-10-18 2001-04-30 Fujisawa Pharmaceutical Co., Ltd. Method for producing liposome preparation
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
WO2013176223A1 (ja) * 2012-05-23 2013-11-28 国立大学法人大阪大学 炎症性疾患治療用医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430455D0 (en) * 1984-12-03 1985-01-09 Fujisawa Pharmaceutical Co Fr-900506 substance
JPH0655676B2 (ja) * 1984-07-26 1994-07-27 ザ リポソ−ム カンパニ−、インコ−ポレ−テツド 脂質小胞体中に含有された抗菌物質の混合物による抗菌活性の増高
JP2838164B2 (ja) * 1988-09-29 1998-12-16 株式会社資生堂 乳化組成物
ES2066915T3 (es) * 1989-07-05 1995-03-16 Fujisawa Pharmaceutical Co Composicion liquida acuosa para uso externo.
AU8007791A (en) * 1990-06-15 1992-01-07 Cytel Corporation Intercellular adhesion mediators

Also Published As

Publication number Publication date
ES2140419T3 (es) 2000-03-01
KR100253492B1 (ko) 2000-05-01
EP0658344A1 (de) 1995-06-21
DE69230541D1 (de) 2000-02-10
ATE188378T1 (de) 2000-01-15
EP0658344A4 (de) 1995-03-02
GR3032319T3 (en) 2000-04-27
CA2122344A1 (en) 1993-05-01
CA2122344C (en) 2004-04-20
DK0658344T3 (da) 2000-04-17
WO1993008802A1 (en) 1993-05-13
EP0658344B1 (de) 2000-01-05

Similar Documents

Publication Publication Date Title
DE3650315D1 (de) Cyancrotonsäureamidverbindung als Arzneimittel mit immunmodulierenden Eigenschaften.
DE69013473T2 (de) Cimetidin enthaltende Arzneimittel.
DE69435295D1 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
DE69813542T2 (de) Arzneizubereitung enthaltend eine trizyklische verbindung mit erhöter stabilität, absorbierbarkeit und niedriger reizungsneigung
ATE121089T1 (de) Optisch aktives 5h-pyrrolo(3,4-b>pyrazinderivat, seine herstellung und pharmazeutische zubereitungen die es enthalten.
ZA926019B (en) Pharmaceutical spheroid formulation.
CA2102697A1 (fr) Derives de pyrrolidine, leur preparation et les medicaments les contenant
AU1225795A (en) Combinations of an organic nitrate and a salicylate
AU650484B2 (en) Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof
DE69228674D1 (de) Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung
RU93058306A (ru) Моногидрат l-тартрата(-)-(s)-2,8-диметил-3-метилен-1-окса-8-азаспиро-(4,5)-декана
NO179586C (no) 4,13-dioksabisyklo[8.2.1Åtridecenonderivater og legemidler inneholdene disse forbindelser
ATE188378T1 (de) Liposompräparat enthaltend eine tricyclische verbindung
HUT70955A (en) 3,4-dihydro-1,1-dioxo-2h-1,2,4-benzothiadiazine-3-carboxylic acid derivatives, preparation thereof and drugs containing same
DE69318153T2 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
ATA124091A (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
CA2077762A1 (en) New use of bambuterol
KR910000645A (ko) 개선된 경련치료제
BR9106372A (pt) Derivados 1,5-benzotiazepinona,suas preparacoes e uso farmaceutico
FI933872A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat
ITMI911344A1 (it) Associazione farmaceutica ad attivita' antineoplastica
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
ATE85618T1 (de) N-heterocyclische propyliden-1,1biphosphons|uren, ihre herstellung und eine pharmazeutische verbindung.
IT9082001A0 (it) Flacone a doppio vano funzionante da contenitore per polvere medicinale e solvente nonche' da camera per la preparazione estemporanea della soluzione.
TH14162EX (th) อนุพันธ์ต่าง ๆ ของแลคแทม

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP

R071 Expiry of right

Ref document number: 658344

Country of ref document: EP